The company has established as its operating objective delivering medicines and supplements at prices that maximize patients' access to its products. It includes selective "Patient Access Programs" for critical life-saving drugs offered at cost in poor regions through local medical institutions.
Paradigm and its sales and medical representatives shall not promote or influence sales with improper and unethical incentives to physicians and pharmacists. From top managment to the ranks of sales and marketing, all colleagues are required to always compliy with the Company's "Business Code of Conduct" ("Orange Book") in their daily conduct of business inside and outside the Company. Colleagues are required periodically to participate in workshops to familiar themeselves with integiry and ehtical behaviors expected of them in their interactions with healthcare professionals, and are required to confirm their compliance by annually signing the Company's Compliance Notification Notice.
Paradigm shall endeavor to increase access to its products for financially poor patients by offering deep discounts, and, for critical life-saving drugs, at cost through selective "Patient Access Programs" in partnership with local medical institutions.
Interacting with healthcare professionals helps us understand and stay up to date on treatment options, efficacy of one medicine over another in same therapeutic area, and obtain other valuable real-life information on prescription medicines and dietary supplements. As this helps us better serve our patients, Paradigm has established programs to engage leading healthcare professionals to share information and medical knowledge with their peers in therapies in which our products are available for treatment.
Most of the dietary supplements, from vitamins and minerals to probiotcs and herbal medicines, are yet to be subjectied to the clinical scrutiny given to pharmaceuticals to establsh their conclusive therapeutic benefits. Yet there exists emperical and scientific evidence, and in some cases convincing clinical evidene, for a number of these natural products. In advancing the concept of Paradigm as a "Complementary Medicines Company," we market only the products with active compounds whose benefits are supported by sufficient scientific and clinical evidence. We make exception for some which although not studied clinically but have been in use for centuries. We are however forthright in telling where the evidence of benefit is insufficient or inconclusive.